3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Renal Cell
14
Neoplasm Metastasis
6
Kidney Neoplasms
5
Breast Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Glioblastoma
3
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Uveal Melanoma
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Hormone Refractory Prostate Cancer
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Fatigue
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma
1
Carcinoid Tumor
1
Brain Neoplasms
1
Interventions
Exercise
9
Walking
3
Early Intervention, Educational
3
Therapeutics
2
Qigong
2
Psychiatric Rehabilitation
2
Physical Therapy Modalities
2
Modafinil
2
Mental Status and Dementia Tests
2
Exercise Therapy
2
Control Groups
2
Carboplatin
2
stinging nettle lectin
1
regorafenib
1
peppermint oil
1
isoquercitrin
1
Whole Body Imaging
1
Vinorelbine
1
Urinalysis
1
Ultraviolet Therapy
1
Taxes
1
Sunitinib
1
Stem Cell Transplantation
1
Standard of Care
1
Saline Solution
1
Restraint, Physical
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Proton Pump Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Fatigue
×
Sunitinib
×
Clear all
NCT02446795
2017-01-18
QUASAR
Consorzio Oncotech
Phase 1/2
Unknown
104 enrolled